Trial intelligence / Profile preview

Salsa: Salbutamol Sandoz vs Ventolin in Children With Asthma

NCT05884970Phase 3Unknown

Sponsor
Canisius-Wilhelmina Hospital
Start
Mar 2023
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of salbutamol in asthma (5 arms), sponsored by Canisius-Wilhelmina Hospital. Primary endpoint: Forced Expiratory Volume in 1 second after 100ug salbutamol. Status: unknown.

02

Drugs

salbutamol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT05884970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05884970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call